Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search


British multinational pharmaceutical, biologics, vaccines and consumer healthcare company.

GlaxoSmithKline (GSK) is in the businesses of pharmaceuticals, vaccines and consumer healthcare. GSK was formerly known as Glaxo Wellcome. The company has centres in the U.S. Belgium, China and the U.K. GSK’s products include treatments for migraines, heart failure and cancer. The company produces vaccines for hepatitis A, hepatitis B and whooping cough. GSK also has dental-care products, over-the-counter medications, nutritional drinks and smoking-cessation products.

GSK’s portfolio includes medicines in respiratory conditions and HIV. Their R&D is focused on the immune system using genetics approaches.


GSK is partnered with the Coalition for Epidemic Preparedness Innovations (CEPI) to use their adjuvant platform to improve immune responses to vaccines, including a collaboration with University of Queensland, Australia, which is developing a potential COVID-19 vaccine. GlaxoSmithKline (GSK) is partnering with Clover Biopharmaceuticals to provide its pandemic adjuvant system for preclinical studies with Clover’s Covid-19 S-Trimer since an adjuvant may reduce the amount of vaccine protein required.


January 2022
Company announced that they had received three unsolicited, conditional and non-binding offers from Unilever to acquire the Consumer Healthcare business unit, with the final proposal valuing the business unit at £50 billion (£41.7 billion in cash, plus £8.3 billion in Unilever shares).
July 2020
GSK acquired a 10% stake in German biotech company CureVac.
October 2019
GSK agreed to sell its rabies vaccine, RabAvert, and its tick-borne encephalitis vaccine, Encepur, to Bavarian Nordic for US$1.06 billion (€955 million).
September 2019
GSK announced it would acquire Sitari Pharmaceuticals and its transglutaminase 2 small molecule program for the treatment of celiac disease.
November 2018
Reuters reported that Unilever was in prime position to acquire GSK's interest in its Indian unit, GlaxoSmithKline Consumer Healthcare Ltd, in a sale that could generate around US$4 billion for the company.
April 2018
With respect to rare diseases, the company divested its portfolio of gene therapy drugs to Orchard Therapeutics
March 2018
GSK announced that it has reached an agreement with Novartis to acquire Novartis's 36.5% stake in their Consumer Healthcare Joint Venture for US$13 billion (£9.2 billion).
December 2017
Reuters reported that Glaxo had increased its stake in its Saudi Arabian unit to 75% (from 49%) taking over control from its Saudi partner Banaja KSA Holding Company.
March 31, 2017
Emma Walmsley became CEO. She is the first female CEO of the company
September 2015
Philip Hampton, at that time chair of the Royal Bank of Scotland, became GSK chairman




Further Resources


Can CRISPR help us do better detective work in the fight on cancer?


November 22, 2021

GSK - Our story


September 12, 2019


July 26, 2021
Consolidated revenue from operations of the company stood at Rs 789.99 crore for the quarter under consideration.
Ben Adams
July 15, 2021
Moderna's market cap hit $100 billion on Wednesday, briefly matching Big Pharma GlaxoSmithKline, as the pandemic cements the once controversial biotech into a major behemoth.
DelveInsight Business Research, LLP
June 24, 2021
/PRNewswire/ -- DelveInsight's Chronic Obstructive Pulmonary Disease (COPD) Market report puts forward a detailed perspective on epidemiology, current...
Julia Kollewe
June 19, 2021
the Guardian
The boss's plan to divide the pharma giant has support - but her own position may hinge on a crucial presentation this week
Research and Markets
June 14, 2021
/PRNewswire/ -- The "Teeth Whitening Market - Global Outlook and Forecast 2021-2026" report has been added to's offering. The teeth...


Golden logo
By using this site, you agree to our Terms & Conditions.